LTC4 synthase / LTC4S antibody
Principal name
LTC4 synthase / LTC4S antibody
Alternative names for LTC4 synthase / LTC4S antibody
Leukotriene C4 synthase, Leukotriene-C(4) synthase
Ncbi ID
9606, NP_665874, NM_145867, NP_665874.1, NP_032547.1, NM_008521
Available reactivities
Available hosts
Available applications
Western blot / Immunoblot (WB)
Background of LTC4 synthase / LTC4S antibody
The MAPEG (Membrane Associated Proteins in Eicosanoid and Glutathione metabolism) family includes a number of human proteins, several of which are involved the production of leukotrienes. LTC4S is an enzyme that catalyzes the first step in the biosynthesis of cysteinyl leukotrienes, potent biological compounds derived from arachidonic acid. Leukotrienes have been implicated as mediators of anaphylaxis and inflammatory conditions such as human bronchial asthma.The MAPEG (Membrane Associated Proteins in Eicosanoid and Glutathione metabolism) family includes a number of human proteins, several of which are involved the production of leukotrienes. This gene encodes an enzyme that catalyzes the first step in the biosynthesis of cysteinyl leukotrienes, potent biological compounds derived from arachidonic acid. Leukotrienes have been implicated as mediators of anaphylaxis and inflammatory conditions such as human bronchial asthma. This protein localizes to the nuclear envelope and adjacent endoplasmic reticulum. Publication Note: This RefSeq record includes a subset of the publications that are available for this gene. Please see the Entrez Gene record to access additional publications.
General readings
Freiberg,J.J., (2008) Arterioscler. Thromb. Vasc. Biol. 28 (5), 990-996



Human Lenti ORF Particles
Catalog No. | ||
---|---|---|
RC206062L2V | Lenti ORF particles, LTC4S (mGFP-tagged) - Human leukotriene C4 synthase (LTC4S), 200 uL, >10^7 TU/mL |
|
![]() |
200 µl /
€930.00
|
|
OriGene Technologies, Inc. | ||
RC206062L1V | Lenti ORF particles, LTC4S (Myc-DDK tagged) - Human leukotriene C4 synthase (LTC4S) , 200 uL, >10^7 TU/mL |
|
![]() |
200 µl /
€830.00
|
|
OriGene Technologies, Inc. | ||